For example, aptamers targeting CD30 have been richly studied in the diagnosis and treatment of ALCL and cHL, and researchers have loaded these aptamers with chemotherapeutic drugs and siRNAs to achieve targeted therapy, resulting in many potential targeted therapeutic regimens. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.